People · Operator
Named in public records as an officer, director or promoter · active 2014–2021 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cardax, Inc. | — | Pharmaceuticals | Seed | $7.3M | $4.1M | 2014 |
David M. Watumull at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David M. Watumull on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David G. Watumull | 1 | 4 |
| Tamar D. Howson | 1 | 3 |
| Frank C. Herringer | 1 | 3 |
| Nicholas G. Mitsakos | 1 | 2 |
| Frank G. Herringer | 1 | 1 |
| John M. Russell | 1 | 1 |
| Michele G. Galen | 1 | 1 |
| Terence A. Kelly | 1 | 1 |
| John B. Russell | 1 | 1 |
| George W. Bickerstaff III | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.